BB Biotech’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,025,476
Closed -$100M 31
2015
Q1
$100M Sell
1,025,476
-105,000
-9% -$10.2M 2.98% 13
2014
Q4
$105M Buy
1,130,476
+37,000
+3% +$3.43M 3.4% 10
2014
Q3
$75.2M Buy
1,093,476
+195,000
+22% +$13.4M 3.06% 12
2014
Q2
$94.2M Sell
898,476
-41,481
-4% -$4.35M 4.47% 8
2014
Q1
$78M Buy
939,957
+81,200
+9% +$6.74M 4.02% 8
2013
Q4
$55.6M Buy
858,757
+144,155
+20% +$9.33M 2.97% 10
2013
Q3
$45.3M Buy
714,602
+661,053
+1,234% +$41.9M 2.46% 12
2013
Q2
$2.25M Buy
+53,549
New +$2.25M 0.16% 23